China Health Group Limited (HKG:0673)
Hong Kong · Delayed Price · Currency is HKD 0.3100
-0.0150 (-4.62%)
Sep 9, 2026, 6:08 PM HKT
China Health Group Revenue
In the fiscal year ending March 31, 2026, China Health Group had annual revenue of 41.09M HKD with 5.52% growth. China Health Group had revenue of 21.48M in the half year ending March 31, 2026, a decrease of -32.15%.
Revenue
41.09M
Revenue Growth
+5.52%
P/S Ratio
10.46
Revenue / Employee
370.20K
Employees
111
Market Cap
430.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.09M | 2.15M | 5.52% |
| Mar 31, 2025 | 38.94M | -20.99M | -35.02% |
| Mar 31, 2024 | 59.93M | -16.48M | -21.57% |
| Mar 31, 2023 | 76.41M | -30.61M | -28.60% |
| Mar 31, 2022 | 107.03M | 19.14M | 21.77% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 660.27B |
| Charmacy Pharmaceutical | 5.40B |
| ETHK Labs | 3.35B |
| Sinco Pharmaceuticals Holdings | 2.22B |
| Sipai Health Technology | 1.83B |
| ClouDr Group | 1.57B |
| 160 Health International | 784.99M |
| Ziyuanyuan Holdings Group | 423.08M |